These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 29513883

  • 1. Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.
    Freitas SCMP, Tavares ER, Silva BMO, Meneghini BC, Kalil-Filho R, Maranhão RC.
    Braz J Med Biol Res; 2018 Jan 23; 51(3):1-8. PubMed ID: 29513883
    [Abstract] [Full Text] [Related]

  • 2. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT, Maranhão RC, Tavares ER, Carvalho PO, Higuchi ML, Mattos FR, Pitta FG, Hatab SA, Kalil-Filho R, Serrano CV.
    J Cardiovasc Pharmacol Ther; 2018 Nov 23; 23(6):561-569. PubMed ID: 29779420
    [Abstract] [Full Text] [Related]

  • 3. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.
    Daminelli EN, Martinelli AE, Bulgarelli A, Freitas FR, Maranhão RC.
    Cardiovasc Drugs Ther; 2016 Oct 23; 30(5):433-443. PubMed ID: 27628679
    [Abstract] [Full Text] [Related]

  • 4. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.
    Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino-Filho AT, Pinto IM, Maranhão RC.
    Clinics (Sao Paulo); 2016 Aug 23; 71(8):435-9. PubMed ID: 27626473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.
    Tavares ER, Freitas FR, Diament J, Maranhão RC.
    Int J Nanomedicine; 2011 Aug 23; 6():2297-304. PubMed ID: 22072867
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery.
    Occhiutto ML, Freitas FR, Lima PP, Maranhão RC, Costa VP.
    Invest Ophthalmol Vis Sci; 2016 Mar 23; 57(3):971-8. PubMed ID: 26962693
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.
    Feio DCA, de Oliveira NCL, Pereira ELR, Morikawa AT, Muniz JAPC, Montenegro RC, Alves APNN, de Lima PDL, Maranhão RC, Burbano RR.
    Int J Nanomedicine; 2017 Mar 23; 12():3827-3837. PubMed ID: 28572727
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel.
    Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhão RC.
    J Pharm Pharmacol; 2002 Jun 23; 54(6):765-72. PubMed ID: 12078992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T, Yamashita S, Takahashi M, Hashimoto H, Mori Y, Goto M.
    Metabolism; 2016 Jun 23; 65(6):893-903. PubMed ID: 27173468
    [Abstract] [Full Text] [Related]

  • 20. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study.
    Marinho LL, Rached FH, Morikawa AT, Tavoni TM, Cardoso APT, Torres RVA, Assuncao AN, Serrano CV, Nomura CH, Maranhão RC.
    Front Cardiovasc Med; 2024 Jun 23; 11():1342832. PubMed ID: 38450375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.